Core Outcome Set (COS) and core outcome instruments (for clinical trials) Clinical signs: Eczema Area and Severity Index (EASI) Patient-reported symptoms: Patient-oriented Eczema Measure (POEM) and NRS-11 for peak itch over past 24 hours) Long term control: (Recap of Atopic Eczema (RECAP) or Atopic Dermatitis Control Tool (ADCT) Quality of Life: DLQI (adults), CDLQI (children), IDQoL (infants) When referencing the HOME core outcome set, please cite this paper: The HOME Core outcome set for clinical trials of atopic dermatitisHywel C Williams, Jochen Schmitt, Kim S Thomas, Phyllis Spuls, Eric L Simpson, Christian J Apfelbacher, Joanne R Chalmers, Masutaka Furue, Norito Katoh, Louise A Gerbens, Yael A Leshem, Laura Howells, Jasvinder A Singh, Maarten Boars, HOME initiativeJ Allergy Clin Immunol. 2022 Jun;149(6):1899-1911. doi: 10.1016\j.jaci.2022.03.017 EPub 2022 Mar 26.
The HOME Core outcome set for clinical trials of atopic dermatitisHywel C Williams, Jochen Schmitt, Kim S Thomas, Phyllis Spuls, Eric L Simpson, Christian J Apfelbacher, Joanne R Chalmers, Masutaka Furue, Norito Katoh, Louise A Gerbens, Yael A Leshem, Laura Howells, Jasvinder A Singh, Maarten Boars, HOME initiativeJ Allergy Clin Immunol. 2022 Jun;149(6):1899-1911. doi: 10.1016\j.jaci.2022.03.017 EPub 2022 Mar 26.
Patient Associations
These videos were recorded by the Association Française de l'Eczéma
Centre of Evidence Based Dermatology University of Nottingham King's Meadow Campus Lenton Lane, Nottingham NG7 2NR, UK
Telephone: +44 115 8232435 Fax: +44 115 8468618 Email: HOME@nottingham.ac.uk
Browser does not support script.